The LLM’s responses may be misleading in certain situations, which could pose problems for patients who trust the medical advice it provides.

New data highlight the significance of tau-positive imaging in the progression of Alzheimer’s disease. 

By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.

A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.

Clinical trial results thus far have been promising, representing a significant step forward for the hundreds of thousands of patients affected by brain metastases. 

Earlier this year, patients treated by an AI chatbot for some common mental health challenges got better. This was significant because the patients were part of the first randomized and controlled trial for this type of AI intervention. 

Some infusion systems manufactured by Zyno Medical were released with unapproved software that could cause safety features to malfunction. Use of any device subject to the recall is to cease immediately. 

The American Medical Association passed a resolution at its recent annual meeting seeking to “maximize trust” around how these models reach conclusions. 
 

The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.